In recent trading, shares of Atea Pharmaceuticals Inc (Symbol: AVIR) have crossed above the average analyst 12-month target price of $51.33, changing hands for $52.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrad
In recent trading, shares of AeroVironment, Inc. (Symbol: AVAV) have crossed above the average analyst 12-month target price of $96.33, changing hands for $125.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
In recent trading, shares of JetBlue Airways Corp (Symbol: JBLU) have crossed above the average analyst 12-month target price of $15.46, changing hands for $15.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
After a solid 2x rise since the March 23 levels of last year, at the current price of around $29 per share we believe Huntsman Corporation stock (NYSE: HUN), a chemicals company best known for its polyurethanes, has reached its near-term potential. HUN stock has rallied from $1
After a solid 3x rise since the March 23 levels of last year, at the current price of around $77 per share we believe MasTec Inc. stock (NYSE: MTZ), an infrastructure and construction company, has reached its near-term potential. MTZ stock has rallied from $26 to $77, significa
Up 40% since March, we believe Motorola Solutions stock (NYSE: MSI) has potential downside of around 15% from its current levels. The company sells data communication and telecommunication equipment and its stock trades at $174 currently, around 5% higher than the level it was
We think that Baxter International (NYSE: BAX) currently is a better pick compared to Boston Scientific (NYSE: BSX). BAX stock trades at about 3.6x trailing Revenues, compared to around 5.2x for Boston Scientific. Does this gap in Baxter’s valuation make se
We believe that Hexcel stock (NYSE: HXL), an industrial materials company that manufactures structural materials for use in aerospace, defense, and industrial markets, is a good buying opportunity at the present time. HXL stock trades near $48 currently and it is, in fact, down
Vaccine developer Novavax (NASDAQ: NVAX) is seen as a key player in the Coronavirus vaccine space. Here’s a quick overview of what has been happening with the company over the last few weeks. Firstly, Novavax initiated a phase 3 study for its Covid-19 vaccine candidate in
Solar stocks have fared well over the last year or so driven by low-interest rates and the recent U.S. Presidential elections, which saw the Democratic party – which is seen as pro-renewable energy – regaining a government trifecta. Two of the best-performing stocks
Tesla (NASDAQ:TSLA) stock has rallied by over 11% over the last 5 trading days and by a solid 23% over the last 10 trading days, driven by strong Q4 vehicle deliveries, which helped the company largely meet its target of selling 500k cars for 2020, and also due to a change in sta
Our theme on Apple Component Supplier Stocks – which includes names such as Qorvo (NASDAQ:QRVO), Qualcomm (NASDAQ: QCOM), and Skyworks Solutions (NASDAQ:SWKS) – returned a solid 59% over 2020, driven by the launch of the iPhones 12 and a broader transition to 5G
Capri Holdings stock (NYSE: CPRI), an apparel marketer and retailer focusing on premium and luxury fashion, under brands Michael Kors, Versace, and Jimmy Choo, became vulnerable during the pandemic due to its nonessential product assortment. Consequently, the company’s re
Qorvo (NASDAQ: QRVO), a semiconductor vendor best known for supplying radio frequency (RF) components had a solid 2020, with its stock price rising by about 60% through the year. The stock is also up almost 3x since the end of 2018 and now trades at about $182 per share. The re
JPMorgan (NYSE: JPM) is scheduled to report its fiscal Q4 2020 results on Friday, January 15. We expect JPMorgan to beat the consensus estimates for revenues, while earnings will likely come in marginally below expectations. The diversified banking giant’s top line benefi
After a solid 2x rise since the March 23 levels of last year, at the current price of around $82 per share we believe Arvinas stock (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments based on targeted protein degradation, has reached its near-term poten
We think that Elanco Animal Health (NYSE: ELAN) currently is a better pick compared to Zoetis (NYSE: ZTS). ELAN stock trades at about 5x trailing Revenues, compared to around 12x for Zoetis. Does this gap in Elanco’s valuation make sense? We don’t thi
A proposed $1.9 trillion coronavirus relief stimulus package from President-elect Joe Biden may prove a double-edged sword for investors, sustaining optimism for further economic revival while raising worries over how the United States will pay for it all.
Washington Federal (WAFD) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.58 per share a year ago. These figures are adjusted for non-recurring items.